Navigation Links
AMIA Announces 2008 Summit on Translational Bioinformatics

Program to address a broad range of topics covering research-related issues and best practices in bioinformatics and computational biology

BETHESDA, Md., June 21, 2007 /PRNewswire-USNewswire/ -- The American Medical Informatics Association (AMIA) Board of Directors, in support of its strategic plan, has approved the development of an annual meeting that will explore topics related to translational bioinformatics. To reflect the growth of novel approaches in genomic medicine and biomedicine at the intersection of clinical care and to better serve its growing member population of translational scientists, AMIA recently added translational bioinformatics as one of its three major strategic domains. This effort, which complements initiatives in comparative medicine within the scientific community, will provide a platform to share innovative research processes that are transforming health care and will strengthen the clinical research enterprise.

"AMIA looks forward to sponsoring its inaugural research meeting focused totally on research in Translational Bioinformatics," says Don E. Detmer, MD, President and CEO. He continues, "AMIA became aware from conversations with experts in this domain that the pace of discovery and growth in this emerging field has outstripped current meeting capabilities. This particular meeting will help 'personalized' care take on a whole new level of meaning and benefit the AMIA community and health care as a whole."

AMIA Board Director, Atul Butte, MD, PhD, Assistant Professor in Medicine (Medical Informatics) and Pediatrics at the Stanford University School of Medicine and the Lucile Packard Children's Hospital, and a board-certified pediatric endocrinologist, will lead the meeting as the Scientific Program Committee chair. Dr. Butte's laboratory focuses on solving problems relevant to genomic medicine by developing new methodologies in translational bioinformatics. He has authored more than 25 publications in bioinformatics, medical informatics, and molecular diabetes and has delivered more than 35 presentations worldwide on bioinformatics, including nine at the National Institutes of Health or NIH-sponsored meetings.

"Translational Bioinformatics is a new sub-discipline and domain within biomedical informatics. In 2005, Dr. Elias Zerhouni, Director of the NIH, wrote that 'At no other time has the need for a robust, bidirectional information flow between basic and translational scientists been so necessary.' Clearly evident in Dr. Zerhouni's quote is the role biomedical informatics needs to play in facilitating translational medicine," said Butte. "As translational bioinformatics is now one of AMIA's major domains of informatics, I am pleased that AMIA will work to build the first national annual meeting for the presentation and discussion of research work in this field, and am proud that AMIA is reaching out to clinical, genomics, and bioinformatics investigators."

The summit will provide a forum to showcase research-related issues among the nationwide initiatives on translational research informatics, such as CTSA, caBIG, NCBC, and others. In addition, the meeting will bring together leaders in the field to create a framework for developing, deploying, and assessing translational bioinformatics initiatives. We anticipate that non- research issues relating to translational bioinformatics and clinical research informatics will continue to be part of the Spring Congress and Annual Symposium.

"With the rapidly emerging and highly visible role of translational bioinformatics as a central component of our national biomedical research enterprise, the opportunities for AMIA and its membership to assume a leadership role in this critical area are significant," comments Philip R. Payne, MD, Assistant Professor of Biomedical Informatics, Ohio State University. "AMIA's recent approval of its third annual meeting, which wi ll focus on the topic of translational bioinformatics, is a clear indicator of the Association's strong commitment to serve as the professional home for practitioners in this domain and as a premier venue for reporting advances in the state of translational research."

The summit will take place March 12-15, 2008 at the Hilton San Francisco in San Francisco, California. A call for participation and program will be announced in the near future. For more information about AMIA's translational bioinformatics activities, visit the AMIA web site at:

    Contact:  Tia Abner

              301-657-1291 ext. 105


About AMIA

The American Medical Informatics Association (AMIA) is a professional organization of leaders shaping the future of biomedical and health informatics in the United States and over 50 other nations. AMIA is dedicated to the development and application of informatics in support of patient care, public health, teaching, research, administration, and related policy. Complete information about AMIA is available at:

CONTACT: Tia Abner of American Medical Informatics Association,+1-301-657-1291 ext. 105,

Web site:

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:10/13/2015)... , Oct. 13, 2015  A minimally-invasive treatment just ... the United States.  After more than 10 years of ... 9 approved the use of High Intensity Focused Ultrasound ... cells while protecting surrounding tissue and minimizing chances for ... George Suarez , a pioneering Miami ...
(Date:10/13/2015)... , Oct. 13, 2015  ContraVir Pharmaceuticals, ... "Company"), a biopharmaceutical company focused on the development ... the closing of its previously announced underwritten public ... and warrants to purchase up to 3,000,000 shares ... combined price to the public of $3.00. The ...
(Date:10/13/2015)... -- Measurement in accountable care programs is essential for ... gaps in measurement can result in missed opportunities ... new, peer-reviewed study published in The ... measurement gaps for high-priority conditions and identifies ways ... --> "These gaps in measures present ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... October 13, 2015 , ... Sir Grout of Greater Boston donated an expansive, ... of Ronald McDonald House Charities® (RMHC®). This donation was made in an effort to ... Boston since its inception. , “We believe strongly in the Ronald McDonald House Charities, ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... ENGAGE, at HIMSS’s Patient Engagement Summit . HealthAware is a technology company ... health programs and interventions via mobile devices that provide a framework for the ...
(Date:10/13/2015)... ... 13, 2015 , ... Element Blue ™, a leading ... company, RightSensor™ LLC, an Internet of Things (IoT) hardware supplier that delivers custom ... approach for customers requiring sensor hardware for critical data environments. , RightSensor™, working ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... NavaFit Inc. ... helps individuals find others to train with, participate in local fitness & sporting ... and Google Play. , “As high medical costs drive us to get more serious ...
(Date:10/13/2015)... (PRWEB) , ... October 13, ... ... Postnatal Omega-3, a first-of-its kind product that targets the unique health needs ... Omega-3” of the American Pregnancy Association ( ), utilizes Nordic Naturals’ ...
Breaking Medicine News(10 mins):